Thursday, May 11, 2023 12:39:46 PM
It's interesting ENZC is moving to sell Biogenysis and Virogentics to Sagaliam at the same time ENZC increased A/S here in the pinks. On the one hand it's a possible fast track to Nasdaq GM for Chandra and those subsidiaries; on the other hand, the hype might support insiders dumping new shares. Increasing A/S would get negative hype if they did it without pairing it with exciting news. It looks savvy or sketchy depending on one's point of view.
There's been an increase in O/S of roughly 90 mil since March 2023. Float on otcmarkets still reflects the March 2022 total.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM